3Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet, 2005,365..63-78. 被引量：1
4Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev, 2003,24 : 341-356. 被引量：1
5Levy MM,Fink MP,Marshall JC,et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med,2003,31:1250-1256. 被引量：1
6Vincent JL,Taccone F, Schmit X. Classification, incidence, and outcomes of sepsis and multiple organ failure. Contrib Nephrol, 2007,156 : 64-74. 被引量：1
7Parker MM,Shelhamer JH, Bacharach SL,et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med, 1984,100 : 483-490. 被引量：1
8Ognibene FP, Parker MM, Natanson C, et al. Depressed left ventricular performance, response to volume infusion in patients with sepsis and septic shock. Chest, 1988, 93:903-910. 被引量：1
9Parker MM, McCarthy KE ,Ognibene FP ,et al. Right ventricu- lar dysfunction and dilatation, similar to left ventricular changes ,characterize the cardiac depression of septic shock in humans. Chest, 1990,97 : 126-131. 被引量：1
10Hartemink KJ, Twisk JW, Groeneveld AB. High circulating N-terminal pro-B-type natriuretic peptide is associated with greater systolic cardiac dysfunction and nonresponsiveness to fluids in septic vs nonseptic critically ill patients. J Crit Care. 2011,26 ; 108. e1-8. 被引量：1
